These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 12934343

  • 1. [Inhalation of beta-2 agonists or corticosteroids as single drugs in comparison with combination therapy of patients with COPD].
    Steurer-Stey C.
    Praxis (Bern 1994); 2003 Jul 30; 92(31-32):1324-5. PubMed ID: 12934343
    [No Abstract] [Full Text] [Related]

  • 2. [Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease].
    Vestbo J.
    Ugeskr Laeger; 2004 Jan 19; 166(4):271-4. PubMed ID: 14964108
    [No Abstract] [Full Text] [Related]

  • 3. [Combination of beta-1 agonist and corticosteroid is advantageous not only in asthma. COPD patients spared exacerbations].
    MMW Fortschr Med; 2002 Oct 31; 144(44):55. PubMed ID: 12494604
    [No Abstract] [Full Text] [Related]

  • 4. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
    Balkissoon R, Make B.
    COPD; 2008 Aug 31; 5(4):221-7. PubMed ID: 18671147
    [Abstract] [Full Text] [Related]

  • 5. [Salmeterol + fluticasone in COPD. Complementary treatment principles hold true in the COPD management, too].
    MMW Fortschr Med; 2003 Nov 13; 145(46):47. PubMed ID: 14699834
    [No Abstract] [Full Text] [Related]

  • 6. Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease.
    Vestbo J, Pauwels R, Anderson JA, Jones P, Calverley P, TRISTSAN study group.
    Thorax; 2005 Apr 13; 60(4):301-4. PubMed ID: 15790985
    [Abstract] [Full Text] [Related]

  • 7. Cardiovascular events in patients with COPD: TORCH study results.
    Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Crim C, Willits LR, Yates JC, Vestbo J, TORCH Investigators.
    Thorax; 2010 Aug 13; 65(8):719-25. PubMed ID: 20685748
    [Abstract] [Full Text] [Related]

  • 8. Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: a 12-week study.
    Korn S, Kerwin E, Atis S, Amos C, Owen R, Lassen C, INSIST study group.
    Respir Med; 2011 May 13; 105(5):719-26. PubMed ID: 21367594
    [Abstract] [Full Text] [Related]

  • 9. Fluticasone/salmeterol: labeling change.
    Prescrire Int; 2008 Dec 13; 17(98):229. PubMed ID: 19418648
    [Abstract] [Full Text] [Related]

  • 10. COPD: treatments benefit patients.
    Rennard SI.
    Lancet; 2003 Feb 08; 361(9356):444-5. PubMed ID: 12583937
    [No Abstract] [Full Text] [Related]

  • 11. COPD: don't use fluticasone + salmeterol. Patients treated with inhaled fluticasone for chronic obstructive pulmonary disease (COPD) are more prone to pneumonia.
    Prescrire Int; 2007 Dec 08; 16(92):257-8. PubMed ID: 18092426
    [No Abstract] [Full Text] [Related]

  • 12. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
    Mapel DW, Nelson LS, Lydick E, Soriano J, Yood MU, Davis KJ.
    COPD; 2007 Jun 08; 4(2):127-34. PubMed ID: 17530506
    [Abstract] [Full Text] [Related]

  • 13. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP.
    Am J Med; 2006 Oct 08; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [Abstract] [Full Text] [Related]

  • 14. Combination therapy in COPD: different response of COPD stages and predictivity of functional parameters.
    Terzano C, Petroianni A, Ricci A, Allegra L.
    Eur Rev Med Pharmacol Sci; 2005 Oct 08; 9(4):209-15. PubMed ID: 16128040
    [Abstract] [Full Text] [Related]

  • 15. Lower inhaled steroid requirement with a fluticasone/salmeterol combination in family practice patients with asthma or COPD.
    Schermer TR, Albers JM, Verblackt HW, Costongs RJ, Westers P.
    Fam Pract; 2007 Apr 08; 24(2):181-8. PubMed ID: 17251178
    [Abstract] [Full Text] [Related]

  • 16. Combined salmeterol and fluticasone for COPD.
    Vassiliou V.
    Lancet; 2003 May 10; 361(9369):1651; author reply 1652-3. PubMed ID: 12747901
    [No Abstract] [Full Text] [Related]

  • 17. Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial.
    Wouters EF, Postma DS, Fokkens B, Hop WC, Prins J, Kuipers AF, Pasma HR, Hensing CA, Creutzberg EC, COSMIC (COPD and Seretide: a Multi-Center Intervention and Characterization) Study Group.
    Thorax; 2005 Jun 10; 60(6):480-7. PubMed ID: 15923248
    [Abstract] [Full Text] [Related]

  • 18. Medications to modify lung function decline in chronic obstructive pulmonary disease: some hopeful signs.
    Suissa S.
    Am J Respir Crit Care Med; 2008 Aug 15; 178(4):322-3. PubMed ID: 18676961
    [No Abstract] [Full Text] [Related]

  • 19. Laryngeal findings in users of combination corticosteroid and bronchodilator therapy.
    Mirza N, Kasper Schwartz S, Antin-Ozerkis D.
    Laryngoscope; 2004 Sep 15; 114(9):1566-9. PubMed ID: 15475783
    [Abstract] [Full Text] [Related]

  • 20. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
    Lindberg A, Szalai Z, Pullerits T, Radeczky E.
    Respirology; 2007 Sep 15; 12(5):732-9. PubMed ID: 17875063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.